According to the Zhitong Finance App, Teda Biotech (08189) announced its results for the third quarter of 2023. The group achieved continuing business turnover of 305 million yuan (RMB, same below) during the period, an increase of 0.08% over the previous year; losses attributable to shareholders of 17.2942 million yuan, a year-on-year decrease of 20.03%; and a basic loss of 0.913 points per share.